Risk Factors Associated with Chemotherapy-Induced Nausea and Vomiting Among Women with Breast Cancer Receiving Highly Emetogenic Chemotherapy: Individual Patient-Based Analysis of Three Prospective Antiemetic Trials.

Autor: Yeo, Winnie, Ngai, Nicole TY, Yip, Christopher CH, Mo, Frankie KF, Yeo, Victoria A, Ko, Jonathan WH, Li, Leung V, Lau, Thomas KH, Lai, Kwai Tung, Pang, Elizabeth, Yip, Claudia HW, Yeo, Horatio L, Kwok, Carol Chi Hei, Ko, Stephanie WY, Molassiotis, Alex

Publikováno v: Cancer Management & Research; Apr2024, Vol. 16, p283-297, 15p

Identification of optimal contemporary antiemetic prophylaxis for doxorubicin-cyclophosphamide chemotherapy in Chinese cancer patients: post-hoc analysis of 3 prospective studies.

Autor: Yeo W; Department of Clinical Oncology, Prince of Wales Hospital, Faculty of Medicine, Hong Kong Cancer Institute, Hong Kong, China.; State Key Laboratory of Translational Oncology, The Chinese University of Hong Kong, Hong Kong, China., Li L; Department of Clinical Oncology, Prince of Wales Hospital, Faculty of Medicine, Hong Kong Cancer Institute, Hong Kong, China., Lau TK; Department of Clinical Oncology, Prince of Wales Hospital, Faculty of Medicine, Hong Kong Cancer Institute, Hong Kong, China., Lai KT; Department of Clinical Oncology, Prince of Wales Hospital, Faculty of Medicine, Hong Kong Cancer Institute, Hong Kong, China., Chan VT; Department of Clinical Oncology, Prince of Wales Hospital, Faculty of Medicine, Hong Kong Cancer Institute, Hong Kong, China., Wong KH; Department of Clinical Oncology, Prince of Wales Hospital, Faculty of Medicine, Hong Kong Cancer Institute, Hong Kong, China., Yip CC; Department of Clinical Oncology, Prince of Wales Hospital, Faculty of Medicine, Hong Kong Cancer Institute, Hong Kong, China., Pang E; Department of Clinical Oncology, Prince of Wales Hospital, Faculty of Medicine, Hong Kong Cancer Institute, Hong Kong, China., Cheung M; Department of Clinical Oncology, Prince of Wales Hospital, Faculty of Medicine, Hong Kong Cancer Institute, Hong Kong, China., Chan V; Department of Clinical Oncology, Prince of Wales Hospital, Faculty of Medicine, Hong Kong Cancer Institute, Hong Kong, China., Kwok CC; Department of Clinical Oncology, Princess Margaret Hospital, Hong Kong, China., Suen JJ; Department of Clinical Oncology, Prince of Wales Hospital, Faculty of Medicine, Hong Kong Cancer Institute, Hong Kong, China., Mo FK; Department of Clinical Oncology, Prince of Wales Hospital, Faculty of Medicine, Hong Kong Cancer Institute, Hong Kong, China.; State Key Laboratory of Translational Oncology, The Chinese University of Hong Kong, Hong Kong, China.

Publikováno v: Cancer biology & medicine [Cancer Biol Med] 2021 Mar 12. Date of Electronic Publication: 2021 Mar 12.